Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

BARD1 Life Sciences Ltd
ASX:BD1

Watchlist Manager
BARD1 Life Sciences Ltd Logo
BARD1 Life Sciences Ltd
ASX:BD1
Watchlist
Price: 1.04 AUD Market Closed
Market Cap: AU$83.3m
Write Note Create Alert Ask AI

Gross Margin

87.5%
Current
No historical data
Comparison unavailable

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
87.5%
=
Gross Profit
AU$446.9k
/
Revenue
AU$511k

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
87.5%
=
Gross Profit
AU$446.9k
/
Revenue
AU$511k

Peer Comparison

Country Company Market Cap Gross
Margin
AU
BARD1 Life Sciences Ltd
ASX:BD1
83.3m AUD
Loading...
US
CVS Health Corp
NYSE:CVS
99.1B USD
Loading...
US
Cigna Corp
NYSE:CI
76.9B USD
Loading...
US
Cigna Group
XMUN:CGN
65.9B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.4B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
23.7B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
23.2B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
23.1B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR
Loading...
US
Guardant Health Inc
NASDAQ:GH
12.8B USD
Loading...
US
DaVita Inc
NYSE:DVA
10.2B USD
Loading...

Market Distribution

Higher than 90% of companies in Australia
Percentile
90th
Based on 2 544 companies
90th percentile
87.5%
Low
-6 907 100% — 21.6%
Typical Range
21.6% — 58.2%
High
58.2% — 2 095.9%
Distribution Statistics
Australia
Min -6 907 100%
30th Percentile 21.6%
Median 38.3%
70th Percentile 58.2%
Max 2 095.9%

Other Profitability Ratios

BARD1 Life Sciences Ltd
Glance View

Market Cap
83.3m AUD
Industry
Health Care

BARD1 Life Sciences Ltd. is a biotechnology company, which engages in the provision of medical services. The firm is engaged in research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer. The Company’s technologies include BARD1, SubB2, NET and hTERT. BARD1 is a biomarker platform covering various tumor markers including nucleic acids, proteins, and autoantibodies for early cancer diagnosis.SubB2M is a pan-cancer probe for monitoring cancer treatment response and recurrence across a wide range of cancers. NET is designed to capture and purify biomarkers, including acids, cells, and exosomes. hTERT is an antibody-based assay to detect hTERT, a component of telomerase, in cells.

BD1 Intrinsic Value
Not Available
What is Intrinsic Value?

See Also

Summary
BD1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
BD1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BD1 stock valuation using valuation multiples.
Wall Street Estimates
BD1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BD1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
87.5%
=
Gross Profit
AU$446.9k
/
Revenue
AU$511k
How has Gross Margin changed over time?

Over the last 6 months, BARD1 Life Sciences Ltd’s Gross Margin has increased from 61.3% to 87.5%. During this period, it reached a low of 61.3% on Dec 31, 2020 and a high of 87.5% on Jul 30, 2021.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.